we are beyond excited to partner with @fidjissimo and the @ChronicleBioAI team as they build a new model for understanding and treating complex, chronic disease. biological heterogeneity hidden within common chronic conditions is one of the grand challenges in medicine. Many conditions remain syndromic rather than mechanistically resolved. patients may share a diagnosis while harboring meaningfully different underlying biology, often without validated biomarkers to distinguish those states. that ambiguity complicates diagnosis, therapeutic selection, and clinical development. the best undiagnosed disease programs solve a version of this problem through deep synthesis across phenotype, molecular data, and clinical expertise. ChronicleBio is bringing a similar level of synthesis to a much broader population and to diseases that affect millions of people. by integrating deep clinical phenotyping, advanced molecular measurement, and AI, the team is working to identify biologically coherent patient subgroups and construct a more granular map of disease. their early work has already surfaced distinct subtypes across complex chronic illness and begun linking those subtypes to potentially relevant therapies. huge thanks to @Forbes for sharing the story. @jimihendrixlive